Solutions
QIC develops domain-specific solutions for drug discovery and financial intelligence—two industries where scientific complexity, data limitations and computational scale create difficult, high-value problems.
01 / Two Industries, Two Critical Challenges
Hit identification, multi-property lead optimization and preclinical ADMET/PK prediction remain costly, uncertain bottlenecks. Data-only AI can struggle when data is sparse, biased or unable to represent the underlying molecular physics.
Credit, portfolio, risk and anomaly problems combine large variable spaces, rare events, changing market conditions and operational constraints. Predictive accuracy alone is not sufficient; models must also be stable, explainable and usable in real workflows.
02 / Solution Portfolio
Innovating the critical bottlenecks in drug development.
QUEST™ applies specialized modules to hit discovery, hit-to-lead and lead optimization, and preclinical prediction—where programs frequently lose time, cost and probability of success.
Explore QUEST™ →Intelligence for prediction, optimization and risk under real constraints.
FintelliQ™ organizes financial Quantum–AI into four solution portfolios and validates selected modules through domain partnerships and industry PoCs.
Explore FintelliQ™ →03 / QIC Solution Principle
QIC’s core competency is knowing which problem in which industry should be addressed, where advanced computation can create value, which technical methodology and algorithm should be applied, and how the result should be validated against domain outcomes.
Frame the real decision, data conditions, operational constraints and success criteria with domain experts.
Select and combine the appropriate AI, quantum method, scientific model and validation approach.
Compare against established methods, experimental evidence and industry requirements.
Explore the Solutions